Morgan Stanley Inventiva S.A. Transaction History

Morgan Stanley

$1.27 Trillion
Q2 2024

A detailed history of Morgan Stanley transactions in Inventiva S.A. stock. As of the latest transaction made, Morgan Stanley holds 1,700 shares of IVA stock, worth $4,556. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,700

Previous 6,300 73.02%

Holding current value

$4,556

Previous $22,000 77.27%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Oct 17, 2024	SELL	$2.62 - $3.89 $12,052 - $17,894	-4,600 Reduced 73.02%	1,700 $5,000
Q2 2024 Aug 14, 2024	SELL	$2.62 - $3.89 $12,052 - $17,894	-4,600 Reduced 73.02%	1,700 $5,000
Q1 2024 Oct 17, 2024	BUY	$3.27 - $4.7 $15,042 - $21,620	4,600 Added 270.59%	6,300 $22,000
Q1 2024 Aug 16, 2024	BUY	$3.27 - $4.7 $1,308 - $1,880	400 Added 6.78%	6,300 $22,000
Q1 2024 May 15, 2024	BUY	$3.27 - $4.7 $1,308 - $1,880	400 Added 6.78%	6,300 $22,000
Q4 2023 Aug 16, 2024	BUY	$3.64 - $4.55 $15,288 - $19,110	4,200 Added 247.06%	5,900 $26,000
Q4 2023 Feb 13, 2024	BUY	$3.64 - $4.55 $16,744 - $20,930	4,600 Added 353.85%	5,900 $26,000
Q3 2023 Nov 15, 2023	SELL	$3.41 - $4.44 $341 - $444	-100 Reduced 7.14%	1,300 $5,000
Q2 2023 Aug 14, 2023	SELL	$2.42 - $4.88 $10,890 - $21,960	-4,500 Reduced 76.27%	1,400 $5,000
Q1 2023 May 15, 2023	SELL	$3.47 - $6.53 $347 - $653	-100 Reduced 1.67%	5,900 $21,000
Q4 2022 Feb 14, 2023	BUY	$3.66 - $7.05 $16,470 - $31,725	4,500 Added 300.0%	6,000 $26,000
Q3 2022 Nov 14, 2022	BUY	$3.69 - $6.05 $1,107 - $1,815	300 Added 25.0%	1,500 $6,000
Q2 2022 Oct 27, 2022	BUY	$5.61 - $12.15 $4,488 - $9,720	800 Added 200.0%	1,200 $7,000
Q2 2022 Aug 15, 2022	BUY	$5.61 - $12.15 $4,488 - $9,720	800 Added 200.0%	1,200 $7,000
Q1 2022 Oct 27, 2022	SELL	$10.51 - $13.66 $8,408 - $10,928	-800 Reduced 66.67%	400 $4,000
Q1 2022 May 13, 2022	BUY	$10.51 - $13.66 $3,153 - $4,098	300 Added 300.0%	400 $4,000
Q3 2021 Nov 15, 2021	BUY	$10.73 - $14.85 $1,073 - $1,485	100 New	100 $1,000

Others Institutions Holding IVA

# of Institutions

Shares Held

4.85M

Call Options Held

Put Options Held

View Full List

About Inventiva S.A.

Ticker IVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,134,200
Market Cap $113M
Description
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company als...

More about IVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account